VASCEPA® (icosapent ethyl) Data from REDUCE-IT® REVASC, Including New Data on Timeframe to Demonstrated Benefit, Presented as Encore at The American Society for Preventive Cardiology 2020 Virtual Summit on CVD (Cardiovascular Disease) Prevention

Paul Theisen
Patient Acquisition

Pat Purcell
Meeting Engagement

Matt Turner
Patient Affordability

Brenda Snow
Authentic Patient Voice

Joey Cohen
Medication Adherence

Stacey Gandler
Brand Nourishment

Daniel Sontupe
Market Access

Suma Ramadas, PhD
Medical Affairs

David Linetsky
Point-of-Care Marketing

Liz Kane
Impactful Strategy

Frank Burrell
Scientific Storytelling

Matthew Durham
Omnidynamic Marketing

Bud Bilanich
Success Coach

Amy Giles
Increasing Engagement